|
LOC647979 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.29709999999272E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.604970E-03 |
| Normal-vs-Stage2 |
1.303370E-01 |
| Normal-vs-Stage3 |
1.202250E-01 |
| Normal-vs-Stage4 |
8.869600E-01 |
| Stage1-vs-Stage2 |
9.007800E-01 |
| Stage1-vs-Stage3 |
8.667600E-01 |
| Stage1-vs-Stage4 |
1.335000E-01 |
| Stage2-vs-Stage3 |
9.845200E-01 |
| Stage2-vs-Stage4 |
3.238800E-01 |
| Stage3-vs-Stage4 |
2.330600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.14229999995208E-06 |
| Normal-vs-AfricanAmerican |
1.141220E-01 |
| Normal-vs-Asian |
4.469000E-01 |
| Caucasian-vs-AfricanAmerican |
4.228300E-02 |
| Caucasian-vs-Asian |
2.228200E-02 |
| AfricanAmerican-vs-Asian |
3.790000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.155200E-04 |
| Normal-vs-Female |
1.031730E-04 |
| Male-vs-Female |
1.414360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.194200E-02 |
| Normal-vs-Extreme_Weight |
2.517900E-02 |
| Normal-vs-Obese |
3.848700E-04 |
| Normal-vs-Extreme_Obese |
8.552600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.645000E-01 |
| Normal_Weight-vs-Obese |
2.165800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.898400E-01 |
| Extreme_Weight-vs-Obese |
1.492960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.457200E-01 |
| Obese-vs-Extreme_Obese |
1.420430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.564600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.59138999999975E-05 |
| Normal-vs-Age(61-80Yrs) |
6.980400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.088800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.360600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.031000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.830300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.325900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.239800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.541000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.17269999991387E-07 |
| Normal-VS-Type2 PRCC |
8.997400E-01 |
| Normal-VS-KIRP CIMP |
2.353600E-01 |
| Normal-VS-Unclassified PRCC |
3.481600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.623560E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.083600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.707800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.179000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.662000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.619600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.906000E-01 |
| Normal-vs-N1 |
6.653700E-02 |
| Normal-vs-N2 |
1.991170E-01 |
| N0-vs-N1 |
3.171800E-01 |
| N0-vs-N2 |
8.261000E-01 |
| N1-vs-N2 |
7.832400E-01 |
|
|
